Abzu's keynote:
"Drug and target discovery with explainable AI."
Given by Lykke Pedersen, Abzu’s Chief Pharma Officer at SAE Media Group’s 14th Annual Conference – RNA Therapeutics.
On the conference:
Investigating the next generation of genetic medicine through RNA-based therapies.
RNA therapeutics is a rapidly expanding industry with increasingly growing potential for immunotherapy, personalised medicines, and treatment of genetic, infectious and chronic diseases.
SAE’s RNA Therapeutics conference explores the latest trends in novel RNA therapies, including developments in AI modeling and small molecule modulation of RNA.
Additionally, topics of novel RNA modalities encompassing self-amplifying RNA, saRNA, circular RNA, lnc RNA were examined.
Drug and target discovery with explainable AI.
Conference keynote abstract:
What is “explainable” artificial intelligence? An intro for scientists and researchers. And why is “explainability” necessary for pharma and life science?
In this keynote, we’ll present an RNA therapeutics use case: Applying explainable AI to augment understanding. Finally, we’ll end with “the future of RNA therapeutics”: How to harness the power of explainable AI to reshape drug development.
Lykke Pedersen presenting “Drug and target discovery with explainable AI.”
We love speaking at RNA therapeutics conferences!
Contact us if you'd like us to present at conferences like SAE Media Group's 14th Annual Conference - RNA Therapeutics.
At Abzu, we look forward to every opportunity to engage with the global RNA therapeutics community at conferences.
Specifically, we excel at sharing our deep expertise in RNA therapeutics, our pioneering work in explainable AI, and our Abzu-lutely infectious personalities.
We truly believe in the transformative potential of our approaches, and we are confident that they are revolutionizing the RNA therapeutics landscape. If you’d like us to speak at your conference, contact us.
